Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “No Metastatic Breast Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 0 results

Large-scale testing (Phase 3)Study completedNCT01958021
What this trial is testing

Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer

Who this might be right for
Advanced, Metastatic Breast Cancer
Novartis Pharmaceuticals 668
Not applicableLooking for participantsNCT03646955
What this trial is testing

Partial Breast Versus no Irradiation for Women With Early Breast Cancer

Who this might be right for
Local Neoplasm RecurrenceDistantly Metastatic Malignant NeoplasmDeath+6 more
Danish Breast Cancer Cooperative Group 926
Testing effectiveness (Phase 2)Study completedNCT00006110
What this trial is testing

Multimodality Treatment for Women With Stage II, Stage III, or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
UNC Lineberger Comprehensive Cancer Center 82
Not applicableNot Yet RecruitingNCT07687225
What this trial is testing

Surgery vs. No Surgery for Primary Tumor in De Novo Stage IV Breast Cancer With Solitary Bone Metastases

Who this might be right for
Breast CancerStage IV Breast CancerBone Metastases
West China Hospital 216
Early research (Phase 1)Study completedNCT00674791
What this trial is testing

Study of Cancer Peptides Vaccine Plus GM-CSF as Adjuvant Treatment for High Risk (TXN2-3M0) or Metastatic Breast Cancer With No Evidence of Disease

Who this might be right for
Breast Cancer
Duke University 13
Not applicableApproved For MarketingNCT01240421
What this trial is testing

An Open-Label, Multi-Center, Expanded Access Program With Eribulin for the Treatment of Advanced Breast Cancer Refractory

Who this might be right for
Metastatic Breast Cancer
Eisai Inc.
Not applicableLooking for participantsNCT07748598
What this trial is testing

HER2+ CNS Surveillance

Who this might be right for
Her 2 Positive Breast CancerCancerCNS
The Clatterbridge Cancer Centre NHS Foundation Trust 69
Not applicableActive Not RecruitingNCT05538000
What this trial is testing

Personalized Preventive Support for Cognitive Impairment in Non-Metastatic Breast Cancer (EFACog)

Who this might be right for
No Metastatic Breast Cancer
Institut de Cancérologie de Lorraine 50
Large-scale testing (Phase 3)Study completedNCT00003010
What this trial is testing

Marimastat or No Further Therapy in Treating Women With Metastatic Breast Cancer That Is Responding or Stable Following Chemotherapy

Who this might be right for
Breast Cancer
Eastern Cooperative Oncology Group 334
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401
What this trial is testing

Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options

Who this might be right for
Solid TumorsCNS Tumors
Hoffmann-La Roche 69
Early research (Phase 1)Study completedNCT02780401
What this trial is testing

Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission

Who this might be right for
HER2/Neu NegativeNo Evidence of DiseaseOne or More Positive Axillary Nodes+8 more
University of Washington 32
Early research (Phase 1)Study completedNCT01259505
What this trial is testing

Safety Study of Multiple-Vaccine to Treat Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Tokyo Medical University 10